Tag: Europe
-
Hydrogel Shown to Boost Beneficial Gut Microbes
Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health.
-
Ginkgo Acquires Bayer Agricultural Biologics Technology
Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership.
-
Trial Begins Testing Crispr Gut Microbiome Therapy
A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers.
-
Biotech Start-Up Begins Longevity Therapy Work
A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process.
-
Preclinical Tests Show Antibody Stops Covid-19 Variants
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2.
-
Biotech Converting CO2 to Food Components Raises $7M
A start-up company creating a process to convert carbon dioxide into food protein elements with microorganisms is raising $7 million in seed funds.
-
AI-Aided Disease Mgmt App Raises $3.8M in Seed Funds
A company creating a mobile app using artificial intelligence to help people manage their chronic diseases raised $3.8 million in seed funding.
-
Patent Board Rules for Broad Inst. in Crispr Case
A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells.
-
Precise Stimulation Shown to Reduce Parkinson Symptoms
Light-activated stimulation of a precise set of nerve cells in the brainstem is shown to improve motor abilities in lab mice induced with Parkinson’s disease.
-
Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.